1. Introduction {#s0005}
===============

In today\'s highly mobile, interdependent and interconnected world, infectious diseases spread at a very fast pace and, consequently, they pose a serious global threat to public health ([@bib89], [@bib18]). The three major global threats of infectious diseases that exist today include emerging infections, antimicrobial resistance and healthcare-associated infections. Over the past decades, newly emerging pathogens, such as the severe acute respiratory syndrome (SARS) or middle east respiratory syndrome (MERS) coronavirus, avian influenza virus, henipavirus and ebola virus, have caused illness and death associated with significant economic burdens ([@bib34], [@bib90], [@bib33]; [@bib58]; [@bib9]). In addition, common microbes such as *Staphylococcus aureus* and *Mycobacterium tuberculosis* have continued to develop resistance to antibiotics ([@bib34], [@bib90], [@bib33]; Institute, 2003; [@bib9]). As a result, more than two million people are now infected with antibiotic-resistant bacteria each year in the US alone, and at least 23,000 people ultimately die as a direct result of these infections ([@bib115], [@bib37], [@bib39]). Lastly, healthcare-associated infections (HAIs) also produce a significant socioeconomic burden (\$150 billion per year in the US) arising from prolonged hospital stays, lasting disabilities and demand for new antibiotics ([@bib82]). To combat the major issues surrounding infectious diseases effectively, rapid and accurate diagnostic methods that can be utilized at the point of care (POC) need to be developed. The availability of these tests eliminates diagnostic delays and uncertainties, enabling timely initiation of proper antibiotic treatments and prevention of the spread of the diseases.

To date, bacterial culture and biochemical staining procedures are the clinical gold standard for bacterial pathogen identification even though these methods require long procedural times (up to several days) from specimen collection to final results and they have only limited use in identifying certain species. Thus, the landscape for infection diagnosis has begun to shift from traditional bacterial culture to POC test systems. For the development of POC diagnostic systems, biosensing technologies that consist of bio-receptors and transducers have been extensively investigated ( [Fig. 1](#f0005){ref-type="fig"}) ([@bib84]). Different recognition elements such as aptamers, antibodies and whole cells have been employed as bio-receptors for the identification of pathogens at the POC. Among these, considerable attention has been given to nucleic acid aptamers, oligonucleotides that have high affinities and specificities toward their targets and that are sometimes called "chemical antibodies" because of their similarities as the bio-receptors. These aptamers are assumed to form secondary/tertiary structures that provide binding pockets for targets ([@bib104]). The high level of interest in these aptamers is also a result of their unique features compared to those of antibodies, which includes low cost of production that does not require living systems, easy chemical modification during the chemical DNA synthesis that leads to custom-tailored properties, low levels of immunogenicity and toxicity that do not interfere with the aptamer selection, and high chemical stability, binding affinity, reproducibility and reusability ([@bib52]).Fig. 1A schematic diagram of infection diagnosis using a biosensor.Fig. 1

Nucleic acid aptamers are screened using an in-vitro selection procedure called a Systematic Evolution of Ligands by EXponential enrichment (SELEX) discovered by Gold and Szostak in the 1990s ([@bib31], [@bib120]). The SELEX process begins with combinatorial oligonucleotide libraries of up to 10^13^ to 10^15^ members, each consisting of an inner random region flanked by two constant regions for polymerase chain reaction (PCR) amplification ([@bib143], [@bib52]). The target molecule of interest is first incubated with the random oligonucleotide libraries (i: incubation) and the members of the libraries that bind to target molecules are separated from nonbinding aptamers (ii: separation). The retained libraries are then applied to PCR amplification (iii: amplification). In this manner, one round of SELEX, comprised of incubation, separation, and amplification is repeated until aptamers with the highest affinities are selected, which typically takes 8--15 rounds (positive selection). In addition, negative selection, in which the oligonucleotide libraries are incubated with negative targets and those that do not bind to negative targets are retained and subjected to further rounds of SELEX, is often executed to improve target specificity. Finally, the selected aptamers are cloned and sequenced to identify sequences and secondary/tertiary structures interacting with target molecules (see [Supporting information](#s0045) for details).

A number of nucleic acid aptamers have been identified using this protocol. These include aptamers that are specific to pathogenic organisms such as gram-positive bacteria (*Staphylococcus aureus, Campylobacter jejuni, Listeria monocytogenes, Lactobacillus acidophilus, Streptococcus pyrogenes, Bifidobacterium bifidum*), gram-negative bacteria (*Escherichia coli, Vibrio parahemolyticus, Salmonella enterica*), *Mycobacterium tuberculosis*, viruses (Avian influenza virus, Human immunodeficiency virus, SARS coronavirus, Human papillomavirus, Hapatitis B virus, Hepatitis C virus, and Ebola virus), protozoa (*Plasmodium falciparum*), and fungi (Several species of *Penicillium, Aspergillus,* and *Fusarium*) ( [Table 1](#t0005){ref-type="table"}). In addition, aptamers that recognize enzymes such as thrombin and DNA polymerase have been utilized to detect pathogenic nucleic acids in a sequence-specific manner ([@bib19], [@bib78], [@bib129], [@bib38], [@bib67], [@bib56], [@bib8], [@bib80], [@bib113]).Table 1Summary of nucleic acid aptamers for the detection of pathogens.Table 1Target organism**TargetType of aptamerLength (nt)**[a](#tbl1fna){ref-type="table-fn"}**Affinity (K**~**d**~**)References***Staphylococcus aureus*Enterotoxin A proteinDNA aptamer8048.57 nM([@bib55])Enterotoxin B proteinDNA aptamer78N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib22])Whole bacteriaRNA aptamer88N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib48])*Campylobacter jenuni*Whole bacteriaDNA aptamer80292.8 nM([@bib30])*Listeria monocytogenes*Internalin A proteinDNA aptamer47N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib95])*Lactobacillus acidophilus*Whole bacteriaDNA aptamer7813 nM([@bib47])*Streptococcus pyrogenes*Whole bacteriaDNA aptamer407 nM([@bib46])*Bifidobacterium bifidum*Whole bacteriaDNA aptamer8011 nM([@bib54])*Escherichia coli*Release factor 1 proteinRNA aptamer8530 nM([@bib112])K88 fibrial proteinDNA aptamer6025 nM([@bib75])Whole bacteriaRNA aptamer64110 nM([@bib74])*Vibrio parahemolyticus*Whole bacteriaDNA aptamer8716.9 nM([@bib28])*Salmonella enterica*Outer membrane protein C (ompC)RNA aptamer4220 nM([@bib49])Outer membrane protein (omp)DNA aptamer40N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib63])Type IVB pili proteinRNA aptamer717.2 nM([@bib97])Whole bacteriaDNA aptamer76123 nM([@bib72])Whole bacteriaDNA aptamer876.3 nM([@bib29])*Mycobacterium tuberculosis*MPT64 proteinDNA aptamer34N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib108])Whole bacteriaDNA aptamer9731 nM([@bib11])Avian influenza virusGlycosylated hemagglutinin protein (Influenza A virus subtype H3N2)RNA aptamer94N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib69])Hemagglutinin protein (Influenza A virus subtype H5N2)RNA aptamer90N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib103])Hemagglutinin (Influenza A virus subtype H5N1)DNA aptamer1154.65 nM([@bib125])PA endonuclease domain (Influenza A virus subtype H5N1)DNA aptamer64137 nM([@bib137])Hemagglutinin (Influenza A virus subtype H9N2)DNA aptamer68N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib17])Hemagglutinin (Influenza B virus)RNA aptamer114720 pM([@bib43])Human immunodeficiency virusReverse transcriptaseDNA aptamer800.19 pM([@bib92])SU glycoprotein2′-F-RNA aptamer[c](#tbl1fnc){ref-type="table-fn"}1145 nM([@bib65])SARS coronavirusNTPase/Helicase (nsP10)RNA aptamer1071.2 nM([@bib60])Human papillomavirus16E7 proteinRNA aptamer751.9 μM([@bib119])Non-tumorigenic HF cell lineDNA aptamer871.6 nM([@bib44])Hepatitis B virusPolymerase (P protein)RNA aptamer61N/A[b](#tbl1fnb){ref-type="table-fn"}([@bib35])Hepatitis C virusNonstructural protein 3RNA aptamer660.99 nM([@bib121])Nonstructural protein 3RNA aptamer7311.6 nM([@bib40])RNA polymeraseRNA aptamer921.5 nM([@bib7])Ebola virusInhibitory domain (eVP35)RNA aptamer703.7 nM([@bib6])*Plasmodium falciparum*Lactate dehydrogenaseDNA aptamer3638.7 nM([@bib73])Several fungal species of the genera *Penicillium and Aspergillus*Ochratoxin ADNA aptamer6696 nM([@bib2])Several fungal species of the genus *Aspergillus*Aflatoxin B1DNA aptamer8011.39 nM([@bib79])Several fungal species of the genus *Fusarium*Fumonisin B−1DNA aptamer96100 nM([@bib85])[^1][^2][^3]

In many types of biosensing platforms, nucleic acid aptamers have been employed as affinity receptors in combination with various signal transduction strategies including colorimetry, chemiluminometry, electrochemistry, fluorometry, and fluorescence anisotropy ([Fig. 1](#f0005){ref-type="fig"}) ([@bib88], [@bib76], [@bib71], [@bib107], [@bib4], [@bib20], [@bib138]). Most importantly, because aptamers change their structures upon binding to target analytes, they can be employed in homogenous assays that utilize a "mix and read" format that does not require separation or washing steps ([@bib23], [@bib116], [@bib51]). Furthermore, because nucleic acid aptamers are comprised of nucleic acids, they can be easily manipulated using isothermal nucleic acid amplification methods to enhance their sensitivities for detection of target pathogens ([@bib83], [@bib81], [@bib5]).

In this review, an overview of systems designed to diagnose infections that are based on nucleic acid aptamers is given using a format that organizes discussion according to their target analytes including pathogenic toxins or proteins, whole cells and nucleic acids. In addition, recent advances made in the development of techniques for sensitive identification of pathogens that rely on the isothermal nucleic acid amplification method are highlighted. Finally, an aptamer-based POC diagnostic system is discussed along with future directions of research in this area.

2. Nucleic acid aptamer-based infection diagnosis {#s0010}
=================================================

In recent years, a large number of researches have utilized aptamers in the design of new biosensors ([@bib50], [@bib106]). The aptamer-based biosensors for infection diagnosis developed to date can be categorized into three classes according to their target pathogenic analytes, which include those that target pathogenic toxins or proteins, whole cells and nucleic acids. In addition, numerous isothermal nucleic acid amplification techniques have been utilized in aptamer-based infection diagnosis for the sensitive determination of pathogenic analytes.

2.1. Aptamer-based detection of pathogenic toxins or proteins {#s0015}
-------------------------------------------------------------

This section focuses on strategies employed to design systems for detecting pathogenic toxins or proteins, which take advantage of the unique structure switching property of nucleic acid aptamers upon interaction with these targets. The first example of an aptamer-based sensor of this type was created to detect ochratoxin A (OTA), a mycotoxin produced by several fungal species of the genera *Aspergillus* and *Penicillium*. Many food crops such as grapes and cereals have been infected by these fungi that produce carcinogenic and neurotoxic OTA, and this has posed serious problems for human and animal health ([@bib86], [@bib1]). Thus, it is necessary to develop fast and reliable approaches for detection of OTA. Thus far, antibody-based immunoassays are the accepted standard for this purpose ([@bib87]), but generation of antibodies for OTA and other toxins is quite difficult because this substance is not tolerated by animals nor is it immunogenic. As a result, conjugation of toxins to carrier proteins is required to enable them to be immunogenic ([@bib1]).

In contrast, because aptamers that are produced using the chemical process termed SELEX have no limitation as to their target molecules, a great number of assays for OTA utilizing nucleic acid aptamers have been described ([@bib110], [@bib98], [@bib93], [@bib142]). One example of this type of detection system utilizes a target-induced strand displacement protocol ([@bib12]). In this method, a fluorescent label (FAM) linked to an aptamer fluoresces inefficiently because the aptamer is hybridized to a complementary blocker DNA containing a quencher (TAMRA). However, the aptamer changes its structure when it binds OTA, causing release of the blocker DNA and a consequent enhancement in the fluorescence intensity ( [Fig. 2](#f0010){ref-type="fig"}A). In a similar way, novel nanomaterials, such as gold nanoparticles, single-walled carbon nanotubes and poly-vinyl pyrrolidone-protected graphene oxides, have been utilized as fluorescence quenchers in place of TAMRA in newly developed OTA sensing strategies ([@bib27], [@bib45], [@bib114]). However, the assays described above require modification or immobilization of aptamers, which increase the overall cost and complexity of the assays.Fig. 2Aptamer-based detection of pathogenic toxins or proteins. (A) An aptamer-based fluorescence assay for the detection of Ochratoxin A using an aptamer modified with a fluorescence label (FAM) and blocker DNA modified with a quencher (TAMRA) ([@bib12]). (B) An aptamer-based label-free, colorimetric assay for the detection of Ochratoxin A using an aptamer linked to a peroxidase mimicking DNAzyme ([@bib131]). (C) An aptamer-based label-free, fluorescence assay for the detection of hemagglutinin protein of H1N1 virus ([@bib36]).Fig. 2

To overcome this drawback, a new detection probe, consisting of a peroxidase mimicking DNAzyme, an OTA-specific aptamer, and a blocker DNA, was designed ([@bib131]). In this method, the DNAzyme initially exists in a caged and inactivated state through its hybridization to the blocker DNA linked to the aptamer. In the presence of OTA, the blocker DNA dissociates from the DNAzyme as a result of interaction of the aptamer with OTA. Consequently, the catalytically active free DNAzyme, produced in this way, promotes a process that leads to an optical response of a colorimetric substrate ([Fig. 2](#f0010){ref-type="fig"}B).

Label-free, fluorescent assays were also developed for the detection of pathogenic proteins. For example, Deng et al. designed a label-free, aptamer-based sensor for detection of H1N1 virus, which operates by targeting the hemagglutinin (HA) protein of avian influenza virus ([@bib36]). This sensor consists of an aptamer for HA protein linked to an oligonucleotide sequence that forms a stem-loop structure. In the absence of HA protein, the hairpin-structured sequence is readily adsorbed on graphene oxide (GO), which prevents production of a new strand when treated with DNA polymerase and, as a result, a low fluorescence response occurs when the double-stranded DNA (dsDNA) specific fluorescent dye, SYBR green I, is added. However, when present, the HA protein binds to the aptamer causing the probe to disassociate from GO, an event that allows DNA polymerase to synthesize a new DNA strand to form a long dsDNA product. As a result, SYBR green I interacts with the dsDNA product to produce a high fluorescence response ([Fig. 2](#f0010){ref-type="fig"}C).

The last example is label-free cantilever sensors for the detection of *Staphylococcus* enterotoxin B (SEB) and fumonisin B-1 (FB1)([@bib140]; [@bib15]). In these systems, binding of either SEB or FB1 to the corresponding aptamers immobilized on the surface of sensing cantilevers, promotes differential surface stress, which consequently creates a measurable deflection signal by the surface stress-based microcantilever. These sensors are able to detect SEB and FB1 over a wide range and with high sensitivities and selectivities.

2.2. Aptamer-based detection of pathogenic whole cells {#s0020}
------------------------------------------------------

In addition to toxins and proteins, whole pathogenic cells can be targeted by aptamers produced using the Cell-SELEX method ([@bib91], [@bib13]). A number of aptamers have been uncovered that target cells of different pathogens including group A *Streptococcus, Salmonella* Typhimurium*, Lactobacillus acidophilus, Mycobacterium tuberculosis, Staphylococcus aureus, Vibrio parahemolyticus and Campylobacter jejuni* ([@bib29]). These aptamers, when combined with different transduction methods ([Fig. 1](#f0005){ref-type="fig"}), serve as bio-receptors for specific detection of target pathogens. The first example of a system of this type is a fluorescent detector for *Salmonella* Typhimurium (*S.* Typhimurium)*,* which causes devastating symptoms such as diarrhea, cramps, vomiting, and fever ( [Fig. 3](#f0015){ref-type="fig"}A) ([@bib29]). In this protocol, *S.* Typhimurium specific DNA aptamers either modified with a fluorescent label (FAM) or linked to magnetic nanoparticles are first incubated with a solution of *S.* Typhimurium, and then washed by using magnetic separation to remove unbound aptamers. Finally, the FAM labeled aptamers bound to *S.* Typhimurim are subjected to fluorescence based quantitative analysis. A similar, but more advanced, chemiluminescence system has been developed for the detection of *Escherichia coli* (*E. coli*). In this sensor, FAM labeled *E. coli* aptamers bound to the bacterial cells are magnetically separated from unbound aptamers by using graphene oxide (GO)/iron (Fe~3~O~4~) nanocomposites, which complex with the unbound aptamers through π--π stacking interactions ([Fig. 3](#f0015){ref-type="fig"}B) ([@bib64]). Finally, the aptamers bound to *E. coli* are assayed using chemiluminescence resonance energy transfer arising from interaction of guanine in the *E. coli* aptamer with 3,4,5-trimethoxylphenylglyoxal hydrate (TMPG) in the presence of tetra-*n*-propylammonium hydroxide (TPA) and N,N-dimethylformamide (DMF). Although being simple and robust, the two new methods still require both fluorescent labeling and tedious washing steps.Fig. 3Aptamer-based detection of pathogenic whole cells. (A) An aptamer-based fluorescence assay for the detection of *S*. Typhimurium using aptamers either modified with a fluorescent label (FAM) or linked to magnetic nanoparticles ([@bib29]). (B) An aptamer-based chemiluminescence assay for the detection of *E. coli* using FAM-labeled aptamers and separation of unbound aptamers by graphene oxide (GO)/Fe~3~O~4~ nanocomposites ([@bib64]). (C) An aptamer-based label-free, washing-free, electrochemical approach for the detection of *L*. *monocytogenes* using the electrostatic interaction of aptamers with protamine ([@bib25]). (D) An aptamer-based colorimetric strategy for the detection of *E. coli* using polydiacetylene (PDA) vesicles modified with aptamers ([@bib126]).Fig. 3

To overcome these limitations, Qin et al. developed a label and washing free electrochemical protocol for the detection of *Listeria monocytogenes* (*L*. *monocytogenes*), which relies on the use of protamine, a group of arginine-rich polycationic proteins bearing positive surface charges ([Fig. 3](#f0015){ref-type="fig"}C). In this method, binding of aptamers specific to *L*. *monocytogenes* target cells effectively prevents them from interacting with protamine ([@bib25]). Consequently, the presence of free protamine is detected by a potential change of a polycation-sensitive membrane electrode.

In addition, aptamer-based colorimetric strategies for the detection of pathogenic cells have also been developed ([@bib126], [@bib3], [@bib10], [@bib135], [@bib136], [@bib54], [@bib72]). A representative example is the approach devised for detection of *E. coli*, which utilizes polydiacetylene (PDA) vesicles. PDAs, formed by UV-light promoted polymerization of diacetylene (DA) monomers, have an initial blue color and undergo a blue to red color transition in response to external stimuli such as temperature, pH, surface pressure and molecular recognition ([Fig. 3](#f0015){ref-type="fig"}D)([@bib126]). Specific binding of aptamer-conjugated PDAs to target cells induces a blue-to-red color change of the PDA that is readily visible to naked eyes. This strategy was used to develop a colorimetric sensor that targets *E. coli* cells. In another effort, a unique sensor that utilizes a lateral flow test strip was developed for a simple, rapid and colorimetric detection of a pathogen. This sensor relies on an aptamer-based sandwich assay in combination with gold nanoparticles and quantum dots as the signal reporters. With the developed system, the target bacteria including *E. coli*, *L*. *monocytogenes* and *S. enterica* are successfully detected with high sensitivities and selectivities ([@bib10]).

2.3. Aptamer-based detection of pathogenic nucleic acids {#s0025}
--------------------------------------------------------

Many attempts have been also made to detect nucleic acids of target pathogenic bacteria utilizing aptamers. An example of this type of detection system uses aptamers, linked to a target recognition sequence, that are covalently conjugated to their corresponding enzymes ([@bib105]). In this system, thrombin, an important protease in the coagulation cascade, is initially inactivated by conjugated thrombin aptamers linked to the target recognition sequence. The presence of the target nucleic acids causes detachment of the aptamers from enzyme and, consequently, transformation of the inactivated enzyme to the active form, which promotes multiple catalytic reactions that result in the generation of highly amplified signals ( [Fig. 4](#f0020){ref-type="fig"}A). Although this strategy, which incorporates enzyme-based signal amplification, enables highly sensitive target DNA detection, it requires complicated and tedious modification processes, which could negatively impact the catalytic activity of enzymes ([@bib102]). In addition, the method is difficult to apply universally to detect different target nucleic acids because the enzymes need to be modified with different DNA probes associated with each target.Fig. 4Aptamer-based detection of pathogenic nucleic acids. (A) An aptamer-based detection of target nucleic acids using thrombin modified with thrombin aptamer linked to target recognition sequence ([@bib105]). (B) An aptamer-based label-free assay for the detection of target nucleic acids using thrombin aptamer engineered to contain a target recognition sequence ([@bib133], [@bib57]). (C) An aptamer-based label-free assay for the detection of target nucleic acids using DNA polymerase aptamer engineered to contain a target recognition sequence ([@bib102]). (D) An assay procedure for POC diagnostic system termed PAD using target-regulated DNA polymerase activity ([@bib100], [@bib99]).Fig. 4

To combat these disadvantages, Ikebukuro et al. designed an aptamer-based nucleic acid detection system that does not involve expensive modifications ([@bib133], [@bib132], [@bib134], [@bib57]). In this method, thrombin aptamers are rationally engineered to contain a target recognition sequence. Thus, complementary target nucleic acids, through its hybridization to a target recognition sequence, regulate the aptamer\'s inhibition of the catalytic coagulation activity of thrombin ([Fig. 4](#f0020){ref-type="fig"}B). As a result, the target DNA can be sensitively detected without the requirement of expensive modifications.

Another interesting approach utilizes a DNA aptamer that possesses an inhibitory activity against DNA polymerase ([@bib19], [@bib78], [@bib129], [@bib38], [@bib67]). In this system, the DNA polymerase aptamer is rationally engineered to contain a target recognition sequence and, thus, DNA polymerase can be activated or inactivated by its hybridization to complementary target DNA ([Fig. 4](#f0020){ref-type="fig"}C)([@bib102]). The regulated DNA polymerase activity is simply measured by using a separated signal transduction module based on a primer extension reaction combined with TaqMan probes. Based on this working principle, Park et al. developed both signal-off and signal-on sensors for target nucleic acids that have high sensitivities and selectivities.

In addition, the practical applicability of this approach was recently demonstrated by its use in a POC diagnostic system, termed polarization anisotropy diagnostics (PAD), for rapid diagnosis of enteric fever and healthcare-associated infections ([Fig. 4](#f0020){ref-type="fig"}D) ([@bib100], [@bib99]). In this study, the entire assay protocol from bacterial RNA extraction to signal detection and portable devices that streamline the POC diagnosis were established. Most importantly, the developed PAD system has several advantageous features. First, it uses a dual-probe scheme wherein target DNA is recognized by a detection probe but the signal is generated by a separate, common reporter system. Thus, the probe can be applied to multiple targets with the minimum incremental cost. Second, because all reactions take place in a single tube without requiring any washing steps, assay procedure is highly streamlined. Third, the system that measures fluorescence anisotropy is inherently ratiometric, automatically canceling fluctuations in light intensity and common environmental noise ([@bib77]). Owing to these novel features, the aptamer-based PAD platform is expected to be a powerful tool for rapid, culture-independent detection of infection and antimicrobial resistance.

2.4. Aptamer-based pathogen detection based on the isothermal nucleic acid amplification {#s0030}
----------------------------------------------------------------------------------------

Another strategy that has been used to design sensitive pathogen detection methods takes advantage of isothermal nucleic acid amplification. It is known that the amount of a target pathogenic marker required to cause a life-threatening illness is quite low. For example, in acutely infected patients, the bacteria level for enteric fever, a febrile illness caused by *Salmonella enterica* serovar Typhi and Paratyphi, is only 0.1--10 colony-forming units (CFU) per 1 mL of blood ([@bib101]). Thus, devising new ultra-sensitive detection methods is highly important. Owing to the fact that aptamers are comprised of nucleic acids, they can be amplified to make aptamer-based pathogen detection systems more sensitive, a distinct advantage when compared to antibody-based detection approaches. In this regard, isothermal nucleic acid amplification techniques are quite promising because they do not require thermal cycling and, as a result, the assay protocol can be easily adapted to POC diagnostic systems. A variety of isothermal nucleic acid amplification techniques have been described and employed in aptamer-based assays. Readers are referred to recent reviews for a more comprehensive overview of isothermal nucleic acid amplification techniques ([@bib5], [@bib24], [@bib42], [@bib141]).

The first example of this type of detection system utilizes target recycling by exonuclease cleavage for ultrasensitive detection of ochratoxin A (OTA) ( [Fig. 5](#f0025){ref-type="fig"}A). In this method, blocker DNA modified with an electroactive label (ferrocene) is immobilized on a gold electrode and hybridized with the aptamer. This causes ferrocene to be located far from the electrode. In its presence, OTA forms a complex with the aptamer, which results in liberation of aptamer from the gold surface. This event produces the free blocker DNA, which forms a hairpin structure through its hybridization at each terminus that places ferrocene close to the electrode surface ([@bib117]). More importantly, OTA is released from aptamer-OTA complex by the action of single-stranded specific exonuclease that digests the aptamer. As a result, an enhanced electrochemical signal is generated by recycling OTA.Fig. 5Aptamer-based pathogen detection based on the isothermal nucleic acid amplification. (A) An aptamer-based electrochemical assay for the sensitive detection of Ochratoxin A using the target recycling by exonuclease cleavage ([@bib117]). (B) An aptamer-based electrochemical assay for the sensitive detection of Ochratoxin A using target-promoted rolling circle amplification (RCA). P in the padlock DNA probe indicates the phosphate group at its 5′ terminus ([@bib118]). (C) An aptamer-based sensitive detection of *S.* Enteritidis using the enriched aptamers as the substrate for strand displacement amplification (SDA) ([@bib32]). (D) An aptamer-based colorimetric assay for the sensitive detection of *S.* Typhimurium using target-triggered exponential amplification reaction (EXPAR) ([@bib109]).Fig. 5

A second example of this approach comes from studies by [@bib118] which focuses on the use of another isothermal nucleic acid amplification method, called rolling circle amplification (RCA), to amplify the output signal. In this method ([Fig. 5](#f0025){ref-type="fig"}B), the OTA aptamer preferentially hybridizes with a padlock DNA probe, which interferes with the circularization of padlock DNA. The presence of OTA results in formation of an OTA-aptamer complex, which causes release of the padlock DNA from the aptamer. As a result, padlock DNA probe becomes circularized by DNA ligase and is then effectively amplified by RCA to produce long single-stranded concatemeric products, which are detected by using fluorescence from quantum dots tagged on the RCA product.

In a similar way, isothermal nucleic acid amplification methods have been rationally integrated into aptamer-based sensing assays for the highly sensitive detection of pathogenic whole cells. One example of this application is found in studies by Fang et al., in which isothermal strand displacement amplification (SDA) was employed in a sensor for the detection of *Salmonella* Enteritidis (*S.* Enteritidis) ([@bib32]). In this method ([Fig. 5](#f0025){ref-type="fig"}C), aptamers anchored on the outer membrane of *S.* Enteritidis serve as the template for subsequent SDA. Thus, aptamers enriched by the presence of target cells generate a large number of amplified ssDNA products through SDA that is mediated by the action of DNA polymerase and a nicking endonuclease. The final products are detected in a lateral flow biosensor system in which the capture DNA probes specific to the amplified ssDNA products are immobilized. Using this novel strategy, as low as 10 CFU of *S.* Enteritidis pathogens can be detected. The same group also demonstrated the universal applicability of this sensing strategy by employing it to detect *E. coli* ([@bib127]).

In addition, an isothermal nucleic acid amplification method, which does not involve enzymes (e.g., DNA polymerase or nicking endonuclease), has been also utilized for the sensitive detection of pathogenic markers ([@bib128]). One example is found in the detection of OTA that relies on the target-triggered hybridization chain reaction (HCR) ([@bib122]). In this method, two types of metastable hairpin probes, one containing OTA-specific aptamer (hairpin 1) and the other containing a peroxidase mimicking DNAzyme in an inactivated state (hairpin 2), stably coexist, but the presence of OTA that interacts with OTA aptamer opens hairpin 1 and the exposed stem of hairpin 1 subsequently invades hairpin 2. In the same manner, hairpin 2 opens hairpin 1 and consequently multiple hairpins are assembled to generate a number of active DNAzymes, which effectively catalyze the color generation reaction, leading to an optical response of a colorimetric substrate.

The last example demonstrates how isothermal nucleic acid amplification serves as the foundation of a simple, sensitive and washing-free detection system for pathogens. The approach ([Fig. 5](#f0025){ref-type="fig"}D) utilizes the target-triggered exponential amplification reaction (EXPAR), an isothermal nucleic acid amplification process that takes place with a high efficiency ([@bib109]). In this method, an aptamer specific to *S.* Typhimurium is partially caged by a blocker DNA, which is designed to open hairpin probe for the subsequent EXPAR (Cycle I). Thus, the presence of target bacteria liberates the blocker DNA, which unfolds the hairpin probe that enables hybridization of the helper. As a result, EXPAR aided by DNA polymerase and a nicking endonuclease occurs to recycle the blocker DNA (Cycle 1) and produce numerous DNAzymes (Cycle 2), that promote an intense colorimetric response through oxidation of 2,2′-azino-bis-(3-ethylbenzothiazoline)−6-sulfonic acid (ABTS) by the peroxidase mimicking activity of DNAzymes. Employing this novel method, target bacteria can be sensitively detected at levels as low as 80 CFU/mL without the requirement for tedious washing steps and expensive DNA modifications.

3. Summary and conclusions {#s0035}
==========================

A high demand exists for diagnostic systems for infectious diseases, which give clinicians the ability to determine the nature of the disease and most effective treatments rapidly. Testing systems of this type eliminate diagnostic uncertainties and, thus, reduce the empirical use of broad-spectrum antimicrobials and facilitate enrollment of new antibiotic treatments. The key requirement of an ideal diagnostic system is the presence of a bio-receptor that specifically identifies the target pathogen. Among many bio-receptors devised for this purpose, nucleic acid aptamers have received the greatest attention because they have unique features such as high stability, low production cost and inherent amplification abilities. Accordingly, various types of nucleic acid aptamer-based sensing strategies have been incorporated with different signal transducers and signal amplifying tools (e.g., isothermal nucleic acid amplification methods) to design systems for the detection of pathogenic toxins, proteins, cells, and nucleic acids.

4. Future perspectives {#s0040}
======================

Despite being founded on well-established detection principles, the number of bio-sensors utilizing aptamers are limited because of the small number of aptamers that have been discovered thus far. It is believed that the scarcity of aptamers is a consequence of two factors. First, it has been reported that natural nucleic acids do not possess the full spectrum of chemical functional groups and conformational space needed to yield high-quality aptamers for many proteomic targets. Thus, it is expected that natural DNA aptamers for less than 30% of the human proteome have been identified ([@bib123]). In this light, chemical methods for DNA synthesis have enabled the incorporation of special functional groups onto oligonucleotides and have led to a significant advancement in the number of diverse aptamers that are available ([@bib66]). An application of this promising approach was recently reported by [@bib41], in a study which not only demonstrated that chemical modification of oligonucleotides significantly increases their affinity, stability and inhibitory potency of aptamers, but also identified a new type of aptamer, called a slow off-rate modified aptamer (SOMAmer). Thus far, SOMAmers against 1300 different protein analytes have been discovered and made commercially available through SomaLogic ([@bib21]). Second, inefficiencies associated with the SELEX process contribute to the small number of aptamers that are currently available. To solve this problem, a number of methods (e.g., Hi-Fi SELEX ([@bib96]), array-based strategies ([@bib16]) and multiparameter particle display strategies ([@bib124])) have been developed, which have led to greater selection efficiencies ([@bib139]).

With these promising results as a foundation, more in-depth research is required in the future to expand aptamer target libraries that cover greater numbers of pathogens. Especially, aptamers that recognize antibiotic-resistance markers and antibiotics are in high demand because of the emerging antimicrobial resistance that increases morbidity, mortality and healthcare costs ([@bib115], [@bib37], [@bib39], [@bib68], [@bib69], [@bib14], [@bib130], [@bib70]). In addition, the host response to the infection together with the pathogenic analytes such as toxins or proteins, whole cells and nucleic acids described in this review creates new attractive targets for the rapid diagnosis of infection especially in the areas where a low pathogenic burden causes a serious infection ([@bib59]). The representative biomarkers in this type of assay are antibody secreting cells that are induced during infection ([@bib61], [@bib62], [@bib111]). In order to analyze infection-specific antibody secreting cells, a high demand exists for bioreceptors with high affinities and selectivities. Aptamers, which have many unique features as compared to those of antibodies, are expected to play a key role in the development of efficient analysis protocols for antibody secreting cells and, consequently, in devising rapid systems for diagnosis of infection.

Finally, robust and affordable POC platforms, which can be deployed in the developing countries where management of infectious disease is not effective, are also required. This goal will be achieved by collaborative efforts involving workers in diverse fields including nanotechnology, microfluidics, molecular biology and medicine ([@bib94]; [@bib53]). Some of the promising results have already arisen from studies of systems for the detection of healthcare-associated infections and malaria infections ([@bib99], [@bib26]). In the near future, these efforts should lead to development of the aptamer-based sensing platforms that will enable rapid and cost-effective detection of infectious diseases and, consequently, that will substantially reduce the human and economic burdens of diseases.
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[^1]: nt: nucleotides.

[^2]: N/A: not available.

[^3]: 2′-F-RNA aptamer: 2′-hydroxyl group in RNA aptamer is changed into 2′-fluorine to improve the stability.
